In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pacific Biosciences of California Inc (NASDAQ: PACB) closed the day trading at $1.77 up 2.91% from the previous closing price of $1.72. In other words, the price has increased by $2.91 from its previous closing price. On the day, 4.0 million shares were traded. PACB stock price reached its highest trading level at $1.8 during the session, while it also had its lowest trading level at $1.72.
Ratios:
For a better understanding of PACB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.14 and its Current Ratio is at 8.01. In the meantime, Its Debt-to-Equity ratio is 1.88 whereas as Long-Term Debt/Eq ratio is at 1.85.
Goldman Downgraded its Buy to Neutral on April 18, 2024, whereas the target price for the stock was revised from $7 to $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 30 ’24 when Kim Susan G. sold 19,782 shares for $1.72 per share. The transaction valued at 34,065 led to the insider holds 695,654 shares of the business.
SUSAN KIM bought 19,782 shares of PACB for $34,061 on Sep 30 ’24. On Sep 16 ’24, another insider, HENRY CHRISTIAN O, who serves as the insider of the company, sold 98,907 shares for $1.75 each. As a result, the insider received 172,692 and left with 2,497,763 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 482376320 and an Enterprise Value of 897525248. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.55 while its Price-to-Book (P/B) ratio in mrq is 0.98. Its current Enterprise Value per Revenue stands at 4.752 whereas that against EBITDA is -3.353.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $10.65, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 4.67%, while the 200-Day Moving Average is calculated to be -37.13%.
Shares Statistics:
Over the past 3-months, PACB traded about 8.24M shares per day on average, while over the past 10 days, PACB traded about 6278010 shares per day. A total of 267.74M shares are outstanding, with a floating share count of 259.36M. Insiders hold about 4.83% of the company’s shares, while institutions hold 83.74% stake in the company. Shares short for PACB as of 1728950400 were 48541467 with a Short Ratio of 5.89, compared to 1726185600 on 46525134. Therefore, it implies a Short% of Shares Outstanding of 48541467 and a Short% of Float of 20.52.
